Allied Biotech (1780) Monthly Revenue

Market: TPEx (OTC) · Industry: Food · 立弘

Allied Biotech (1780) reported revenue of NT$104.4 million for Oct 2026, +29.0% year on year and +18.3% from the previous month. Revenue for Jan–Oct 2026 was NT$848.4 million (+18.4% year on year).

Revenue for Oct 2026 was a record high (previous high: Apr 2026, NT$103.2 million). →

Year-on-year revenue growth: 4 months in a row. →

In Oct 2026, it ranked No. 26 by revenue among 34 Food companies.

Monthly revenue chart

Oct 2024 NT$51.9 million24/10Nov 2024 NT$69.8 millionDec 2024 NT$64.5 millionJan 2025 NT$73.4 millionFeb 2025 NT$79.5 million25/02Mar 2025 NT$56.9 millionApr 2025 NT$89.9 millionMay 2025 NT$58.7 millionJun 2025 NT$67.1 million25/06Jul 2025 NT$72.5 millionAug 2025 NT$66.5 millionSep 2025 NT$71.1 millionOct 2025 NT$81 million25/10Nov 2025 NT$66.4 millionDec 2025 NT$66.6 millionJan 2026 NT$73.9 millionFeb 2026 NT$93.6 million26/02Mar 2026 NT$72.8 millionApr 2026 NT$103.2 millionMay 2026 NT$92.2 millionJun 2026 NT$62.7 million26/06Jul 2026 NT$82.5 millionAug 2026 NT$74.8 millionSep 2026 NT$88.2 millionOct 2026 NT$104.4 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$104.4 million+29.0%+18.3%
Sep 2026NT$88.2 million+24.1%+17.9%
Aug 2026NT$74.8 million+12.5%-9.3%
Jul 2026NT$82.5 million+13.8%+31.6%
Jun 2026NT$62.7 million-6.4%-32.0%
May 2026NT$92.2 million+57.0%-10.6%
Apr 2026NT$103.2 million+14.7%+41.8%
Mar 2026NT$72.8 million+28.0%-22.2%
Feb 2026NT$93.6 million+17.8%+26.6%
Jan 2026NT$73.9 million+0.7%+11.0%
Dec 2025NT$66.6 million+3.1%+0.3%
Nov 2025NT$66.4 million-4.9%-18.0%
Oct 2025NT$81 million+56.1%+13.9%
Sep 2025NT$71.1 million+17.2%+6.8%
Aug 2025NT$66.5 million+14.4%-8.3%
Jul 2025NT$72.5 million-2.0%+8.2%
Jun 2025NT$67.1 million+9.6%+14.2%
May 2025NT$58.7 million-12.9%-34.7%
Apr 2025NT$89.9 million+38.0%+58.2%
Mar 2025NT$56.9 million-25.7%-28.5%
Feb 2025NT$79.5 million+9.8%+8.3%
Jan 2025NT$73.4 million-13.9%+13.7%
Dec 2024NT$64.5 million+65.0%-7.5%
Nov 2024NT$69.8 million+22.2%+34.5%
Oct 2024NT$51.9 million-21.4%-14.4%

Jan–Oct 2026 cumulative: NT$848.4 million (+18.4% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Food companies

Compare with peers: Allied Biotech vs UNI-PRESIDENT / Allied Biotech vs GREATWALL / Allied Biotech vs CPE

CompanyRevenueYoY
UNI-PRESIDENT1216NT$57.1 billion+5.3%
GREATWALL1210NT$9.66 billion+14.6%
CPE1215NT$2.66 billion+13.4%
TTET1232NT$2.48 billion+33.4%
SFC1227NT$2.08 billion-3.5%
WEI CHUAN1201NT$1.88 billion+4.4%
NAMCHOW1702NT$1.87 billion+3.1%
LHIHC1229NT$1.1 billion+8.0%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16